Grid Therapeutics Collaborates with Catalent to Develop the First Human-Derived Antibody for the Treatment of Cancer Posted on October 31, 2017, in News, Press Releases wp_link_pages( array( 'before' => ' ' . esc_html__( 'Pages:', 'gridtherapeutics' ), 'after' => ' ', ) ); ?> Read more